An independent model, in which human A3B (as a turbo-GFP fusion) is integrated at the ColA1 locus and expressed inducibly using a R26-integrated tetracycline transactivator,21 also yields modest A3B expression levels and no significant tumor phenotypes (Figure S3). The gene discussed is APOBEC3B; the disease is neoplasm.